European Archives - Page 65 of 1138 - European Medical Journal

Aspirin and COX-1 Inhibitors Show Promise in Preventing Cancer Metastasis

Aspirin and COX-1 inhibitors may reduce cancer metastasis by enhancing T cell immunity, offering a new treatment approach.

Annual Lenacapavir Injection Could Revolutionise HIV PrEP

New findings highlight the potential of once-yearly intramuscular lenacapavir for PrEP, offering a long-acting alternative that could reduce barriers to HIV prevention.

Intestinal Ultrasound Detects Hidden IBD Risks During Pregnancy

A large international study shows that intestinal ultrasound during pregnancy can reveal hidden inflammatory bowel disease activity, significantly improving prediction of complications like preterm birth and preeclampsia, beyond what clinical symptoms and lab tests can detect.

Risk Factor Count Determines Skin Cancer Progression

From a therapeutic perspective, these findings advocate for a more tailored approach to treatment.

Broken Heart Syndrome: Machine Learning Identifies the Key Mortality Risks

Machine learning model predicts death risk in broken heart syndrome with 84% accuracy, a new study reveals.

Managing Catheter-Related Bladder Discomfort After Surgery

A randomised pilot study investigated whether scheduled IV acetaminophen administration would offer longer-lasting relief than a single dose.

Minimal Residual Disease May Predict NSCLC Recurrence After Osimertinib

Molecular residual disease detection may help identify patients with EGFR-mutated NSCLC who could benefit from prolonged adjuvant osimertinib

Deep-Learning Models Could Improve Hepatocellular Carcinoma Prognosis

Deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in hepatocellular carcinoma.

At-Home Smell Test Detects Early Cognitive Decline in Alzheimer’s

A new study reveals how an at-home smell test can detect early cognitive decline, aiding Alzheimer’s screening.

Reduced-Dose Apixaban Effective for Cancer-Related Blood Clots

Reduced-dose apixaban prevents recurrent blood clots in cancer patients, with fewer bleeding complications, offering a safer treatment option.